GlassScriptPhysician profile
Anicia Nicole Howard
NPI 1265102305
$1,007.47
in general payments reported to CMS, 2019-2025
22 companies · $513 in 2025
The $513 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $98.30 · 2024: $396 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $120.89 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $116.83 | 2023-2024 | Dificid, Zerbaxa, Recarbrio |
| Hollister Incorporated | $115.12 | 2025 | New Image, Hollister, Adapt Ceraring |
| Astellas Pharma US INC | $105.92 | 2024 | Veozah |
| Aroa Biosurgery Incorporated | $72.68 | 2024-2025 | |
| Exact Sciences Corporation | $66.26 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kerecis Limited | $46.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $46.08 | 2023-2025 | Enseal, Echelon Circular |
| Braintree Laboratories, INC. | $37.06 | 2025 | Suflave, Sutab |
| Millicent US INC | $33.63 | 2024-2025 | Intrarosa |
| Teleflex LLC | $30.76 | 2025 | Deflux Metal Needle |
| Azurity Pharmaceuticals, INC. | $27.68 | 2025 | Suflave |
| Boston Scientific Corporation | $25.63 | 2025 | Axonics |
| Hologic Sales and Service, LLC | $24.44 | 2025 | Novasure |
| Medtronic, INC. | $20.96 | 2024 | Interstim |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $20.23 | 2024 | Axonics |
| Acera Surgical, INC. | $19.49 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $16.80 | 2024 | Activ.A.C., Prevena |
| Reprise Biomedical, INC. | $16.67 | 2025 | Miro3d |
| Biogen, INC. | $16.61 | 2025 | Zurzuvae |
| Davol INC. | $13.98 | 2025 | Arista |
| Mayne Pharma Commercial LLC | $13.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anicia Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.